News

• Raising support for VPH in the H2020 Work Programme for Health, demographic change and wellbeing

  We need everybody help to stress the importance of in silico medicine in the work programme for Health: support our policy activities!

  -Read more-

• Avicenna kicks off on Oct 1st

  The beginning of the 21st century saw the birth of a completely new way to investigate living organisms through computer simulations, called in silico medicine. This coordination and support action, named after the great physician Avicenna, will explore systematically how computer simulations can be used to improve clinical trials of drugs, devices, and biotechnology products.

  -Read more-

• Slow progress on Data Protection Regulation

  The European Parliament’s Civil Liberties, Justice and Home Affairs Committee (LIBE) is being seen to make slow progress on the proposed Data Protection Regulation, which has the potential to impact on the ability of VPH members to access data.

  -Read more-

• Parliamentary Question on Healthcare Data Digitalisation

  On 1 July 2013, Amelia Andersdotter (Greens/EFA, Sweden) has asked the European Commission about what it intends to do regarding plans by Member States in Central and Eastern Europe to create data digitalisation system, and particularly about the security risk to patients’ data this undertaking might pose.

  -Read more-

• Clinical Trials Transparency Debate

  The EurActiv released on 30 August 2013 an article entitled “Health experts critical of pharma industry's new transparency rules”, and shows that the balance between the commercial interest of pharmaceutical companies and the benefit for patients is still being contested at EU level.

  -Read more-

• Networking session on 'in silico medicine' during ICT 2013

  The VPH Institute was selected to lead one of the networking sessions that will take place at the ICT2013 conference in Vilnius (6-8 November 2013). You are all invited to attend and give your contribution.

  -Read more-